Microbiome Improvement by Hangeshashinto in diarrhea-type irritable bowel syndrome: MI-HAN study

Microbiome Improvement by Hangeshashinto in diarrhea-type irritable bowel syndrome: MI-HAN study - Microbiome Improvement by Hangeshashinto in diarrhea-type irritable bowel syndrome: MI-HAN study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053629

Enrollment

100

Registered

2024-02-15

Start date

2022-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diarrhea-type irritable bowel syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients diagnosed with IBS-D based on the ROME IV criteria

Exclusion criteria

Exclusion criteria: Patients with IBD, serious fatal disease, and those taking other herbal medicines

Design outcomes

Primary

Measure	Time frame
The efficacy of Hangeshashinto to IBS-D	—

Secondary

Measure	Time frame
The changes of microbiome by Hangeshashinto	—

Countries

Japan

Contacts

Public ContactNaohisa Yoshida

Kyoto Prefectural Univedrsity of Medicine Molecular Gastroenterology and Hepatology

naohisa@koto.kpu-m.ac.jp0752515519

Outcome results